356 related articles for article (PubMed ID: 17129830)
1. Knowledge-based chemoinformatic approaches to drug discovery.
Ghose AK; Herbertz T; Salvino JM; Mallamo JP
Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
[TBL] [Abstract][Full Text] [Related]
2. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
3. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
4. Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
Vanderwall DE; Yuen N; Al-Ansari M; Bailey J; Fram D; Green DV; Pickett S; Vitulli G; Luengo JI; Almenoff JS
Drug Discov Today; 2011 Aug; 16(15-16):646-53. PubMed ID: 21601652
[TBL] [Abstract][Full Text] [Related]
5. Strategies for designing GPCR-focused libraries and screening sets.
Jimonet P; Jäger R
Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
[TBL] [Abstract][Full Text] [Related]
6. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
7. [Chemoinformatics and virtual screening of molecules for therapeutic use].
Vayer P; Arrault A; Lesur B; Bertrand M; Walther B
Med Sci (Paris); 2009 Oct; 25(10):871-7. PubMed ID: 19849994
[TBL] [Abstract][Full Text] [Related]
8. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
9. A knowledge-based weighting approach to ligand-based virtual screening.
Stiefl N; Zaliani A
J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987
[TBL] [Abstract][Full Text] [Related]
10. Crystallization to obtain protein-ligand complexes for structure-aided drug design.
Danley DE
Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):569-75. PubMed ID: 16699182
[TBL] [Abstract][Full Text] [Related]
11. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
Guo ZR
Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
[TBL] [Abstract][Full Text] [Related]
12. Molecular optimization using computational multi-objective methods.
Nicolaou CA; Brown N; Pattichis CS
Curr Opin Drug Discov Devel; 2007 May; 10(3):316-24. PubMed ID: 17554858
[TBL] [Abstract][Full Text] [Related]
13. Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery.
Tintori C; Corradi V; Magnani M; Manetti F; Botta M
J Chem Inf Model; 2008 Nov; 48(11):2166-79. PubMed ID: 18942779
[TBL] [Abstract][Full Text] [Related]
14. [Strategy of molecular drug design: hits, leads and drug candidates].
Guo ZR
Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
[TBL] [Abstract][Full Text] [Related]
15. Prediction of potential drug targets based on simple sequence properties.
Li Q; Lai L
BMC Bioinformatics; 2007 Sep; 8():353. PubMed ID: 17883836
[TBL] [Abstract][Full Text] [Related]
16. Evolving molecules using multi-objective optimization: applying to ADME/Tox.
Ekins S; Honeycutt JD; Metz JT
Drug Discov Today; 2010 Jun; 15(11-12):451-60. PubMed ID: 20438859
[TBL] [Abstract][Full Text] [Related]
17. Developing a drug-like natural product library.
Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. The properties of known drugs. 1. Molecular frameworks.
Bemis GW; Murcko MA
J Med Chem; 1996 Jul; 39(15):2887-93. PubMed ID: 8709122
[TBL] [Abstract][Full Text] [Related]
20. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
Beaumont K; Smith DA
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
